…esigned studies. To focus on the metastatic setting relevant to oligometastatic disease, trials referring to early-stage (stage I–II) or locally advanc…
NSCLC
This disease is selected. Its supporting articles are shown below.
Articles mentioning NSCLC
189 articles · page 1 of 16…land during the pandemic.36 37 In the years following 2020, the lung cancer diagnoses have increased, but SACT treatment rates have been sl…
…performed a prospective study (n=113) in patients with advanced NSCLC treated with single agent ICIs and correlated clinopathological…
…I; and the American Lung Association and Lung Cancer Europe for NSCLC. Selection of patient-advocacy organisations was guided by thre…
…s (CE) of adjuvant, neoadjuvant and perioperative therapies for stage II–III non-small-cell lung cancer: results based on 1000 Monte-Carlo simulations (male population…
…dagrasib, evaluated in KRYSTAL-1, showed comparable efficacy in NSCLC (ORR ~43%, PFS 6.5 months, OS 12.6 months) and similarly receiv…
…erexpression is associated with tumour metastasis, including in lung cancer. Targeting TAM receptors encourages M1 macrophage polarisation …
…cell-mediated tumor cell killing activity and a syngeneic mouse NSCLC model were used to assess the influence of USP15 and U10 on NSC…
…T cells (Tregs; 8.09% vs. 4.18%, P < 0.05) in anti-PD-1-treated NSCLC patients compared to untreated controls. These findings implica…
…topic and subcutaneous tumors and increased radiosensitivity of NSCLC cell lines by suppressing proliferation and promoting apoptosis…
…Background Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and the leading …
…cines. 2023;11(2):508.Liu C, Huang Y, Cui Z, et al. KRAS-mutant non-small cell lung cancer: from molecular heterogeneity to clinical management. Cancer Co…